{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:08:28Z","timestamp":1793376508278,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2022-ER2202\\u201300"],"award-info":[{"award-number":["2022-ER2202\\u201300"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jgar.2025.04.005","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T02:11:48Z","timestamp":1745201508000},"page":"86-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Therapeutic potential of novel phages with antibiotic combinations against ESBL-producing and carbapenem-resistant Escherichia Coli"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1916-5888","authenticated-orcid":false,"given":"Md","family":"Shamsuzzaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1795-1844","authenticated-orcid":false,"given":"Jungmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jgar.2025.04.005_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-023-05745-7","article-title":"Carbapenem-resistant Escherichia coli exhibit diverse spatiotemporal epidemiological characteristics across the globe","volume":"7","author":"Huang","year":"2024","journal-title":"Communications Biology"},{"key":"10.1016\/j.jgar.2025.04.005_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.162807","article-title":"One global disseminated 193 kb high-risk hybrid plasmid harboring tet(X4), mcr or blaNDM threatening public health","volume":"876","author":"Li","year":"2023","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jgar.2025.04.005_bib0003","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum \u03b2-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2025.04.005_bib0004","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/pathogens9010065","article-title":"High prevalence of CTX-M type extended-spectrum beta-lactamase genes and detection of NDM-1 carbapenemase gene in extraintestinal pathogenic Escherichia coli in Cuba","volume":"9","author":"Qui\u00f1ones","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.jgar.2025.04.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlab092","article-title":"Extended-spectrum \u03b2-lactamases: an update on their characteristics, epidemiology and detection","volume":"3","author":"Castanheira","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.jgar.2025.04.005_bib0006","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4103\/0974-777X.68531","article-title":"Extended-spectrum \u00df-lactamases in gram negative bacteria","volume":"2","author":"Rawat","year":"2010","journal-title":"J Glob Infect Dis"},{"key":"10.1016\/j.jgar.2025.04.005_bib0007","doi-asserted-by":"crossref","unstructured":"Green S.I., Kaelber J.T., Li M., Trautner B.W., Ramig R.F., Maresso A.W. Bacteriophages from ExPEC reservoirs kill pandemic multidrug-resistant strains of clonal group ST131 in animal models of bacteremia 2017. https:\/\/doi.org\/10.1038\/srep46151.","DOI":"10.1038\/srep46151"},{"key":"10.1016\/j.jgar.2025.04.005_bib0008","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1016\/S2666-5247(21)00124-5","article-title":"WHO 2020 report on the antibacterial production and development pipeline","volume":"2","author":"Venkatesan","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jgar.2025.04.005_bib0009","doi-asserted-by":"crossref","unstructured":"Suay-Garc\u00eda B., Teresa P\u00e9rez-Gracia M. antibiotics present and future of carbapenem-resistant Enterobacteriaceae (CRE) infections 2019. https:\/\/doi.org\/10.3390\/antibiotics8030122.","DOI":"10.3390\/antibiotics8030122"},{"key":"10.1016\/j.jgar.2025.04.005_bib0010","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.19.2300209","article-title":"Rapid cross-border emergence of NDM-5-producing Escherichia coli in the European Union\/European Economic Area, 2012 to June 2022","volume":"28","author":"Linkevicius","year":"2023","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jgar.2025.04.005_bib0011","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jinf.2023.02.004","article-title":"Population genomic analysis reveals the emergence of high-risk carbapenem-resistant Escherichia coli among ICU patients in China","volume":"86","author":"Zhang","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.jgar.2025.04.005_bib0012","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/fpd.2024.0023","article-title":"Therapeutic phage candidates for targeting prevalent sequence types of carbapenem-resistant Escherichia coli","volume":"21","author":"Shamsuzzamn","year":"2024","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.jgar.2025.04.005_bib0013","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s12275-018-8310-1","article-title":"Characterization of a Salmonella Enteritidis bacteriophage showing broad lytic activity against gram-negative enteric bacteria","volume":"56","author":"Kim","year":"2018","journal-title":"J Microbiol"},{"key":"10.1016\/j.jgar.2025.04.005_bib0014","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/1574-6976.12072","article-title":"Bacteria\u2013phage coevolution as a driver of ecological and evolutionary processes in microbial communities","volume":"38","author":"Koskella","year":"2014","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jgar.2025.04.005_bib0015","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.7150\/ijbs.60551","article-title":"A combination therapy of phages and antibiotics: two is better than one","volume":"17","author":"Li","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jgar.2025.04.005_bib0016","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","article-title":"Formulation, stabilisation and encapsulation of bacteriophage for phage therapy","volume":"249","author":"Malik","year":"2017","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.jgar.2025.04.005_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02573-17","article-title":"Design of a broad-range bacteriophage cocktail that reduces pseudomonas aeruginosa biofilms and treats acute infections in two animal models","volume":"62","author":"Forti","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.04.005_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1455710","article-title":"Bacteriophage as a novel therapeutic approach for killing multidrug-resistant Escherichia coli ST131 clone","volume":"15","author":"Shamsuzzaman","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2025.04.005_bib0019","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2175519","article-title":"The applications of animal models in phage therapy: an update","volume":"19","author":"Mehmood Khan","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jgar.2025.04.005_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1225282","article-title":"Genome insight and probiotic potential of three novel species of the genus Corynebacterium","volume":"14","author":"Shamsuzzaman","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2025.04.005_bib0021","first-page":"1","article-title":"Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry","volume":"11","author":"Liu","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.jgar.2025.04.005_bib0022","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1128\/iai.63.4.1263-1269.1995","article-title":"Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo","volume":"63","author":"Russo","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.jgar.2025.04.005_bib0023","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3906\/sag-1407-62","article-title":"Molecular characteristics of extended spectrum \u00df-lactamase and carbapenemase genes carried by carbapenem-resistant Enterobacter cloacae in a Chinese university hospital","volume":"45","author":"Cui","year":"2015","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.jgar.2025.04.005_bib0024","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.3390\/biomedicines11112937","article-title":"Extended-spectrum \u03b2-lactamases (ESBL): challenges and opportunities","volume":"11","author":"Husna","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jgar.2025.04.005_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-023-05745-7","article-title":"Carbapenem-resistant Escherichia coli exhibit diverse spatiotemporal epidemiological characteristics across the globe","volume":"7","author":"Huang","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.jgar.2025.04.005_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108826","article-title":"Diverse bacteriophages for biocontrol of ESBL- and AmpC-\u03b2-lactamase-producing E. coli","volume":"27","author":"Vitt","year":"2024","journal-title":"IScience"},{"key":"10.1016\/j.jgar.2025.04.005_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199126","article-title":"BL02, a phage against carbapenem- and polymyxin-B resistant Klebsiella pneumoniae, isolated from sewage: a preclinical study","volume":"331","author":"Liang","year":"2023","journal-title":"Virus Res"},{"key":"10.1016\/j.jgar.2025.04.005_bib0028","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01652-19","article-title":"Resistance evolution against phage combinations depends on the timing and order of exposure","volume":"10","author":"Wright","year":"2019","journal-title":"MBio"},{"key":"10.1016\/j.jgar.2025.04.005_bib0029","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3390\/v14112502","article-title":"Integrated omics reveal time-resolved insights into T4 phage infection of E. coli on proteome and transcriptome levels","volume":"14","author":"Wolfram-Schauerte","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jgar.2025.04.005_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2022.108479","article-title":"Whole genome sequencing and in vitro activity data of Escherichia phage NTEC3 against multidrug-resistant uropathogenic and extensively drug-resistant uropathogenic E. coli isolates","volume":"43","author":"Chaudhary","year":"2022","journal-title":"Data Brief"},{"key":"10.1016\/j.jgar.2025.04.005_bib0031","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/antibiotics10020124","article-title":"Phage-encoded endolysins","volume":"10","author":"Abdelrahman","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.jgar.2025.04.005_bib0032","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2273567","article-title":"Potential of phage depolymerase for the treatment of bacterial biofilms","volume":"14","author":"Guo","year":"2023","journal-title":"Virulence"},{"key":"10.1016\/j.jgar.2025.04.005_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.825828","article-title":"Bacteriophage-mediated control of Biofilm: a promising new dawn for the future","volume":"13","author":"Chang","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2025.04.005_bib0034","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3390\/ijms25020854","article-title":"Therapeutic potential of a novel lytic phage, vB_EclM_ECLFM1, against carbapenem-resistant Enterobacter cloacae","volume":"25","author":"Ali","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jgar.2025.04.005_bib0035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12088-023-01074-9","article-title":"Evaluation of the lytic activity of various phage cocktails against, ESBL-producer, non-producer and carbapenem-resistant Escherichia coli isolates","volume":"63","author":"Uskudar-Guclu","year":"2023","journal-title":"Indian J Microbiol"},{"key":"10.1016\/j.jgar.2025.04.005_bib0036","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3390\/antibiotics12081329","article-title":"The potential of bacteriophage-antibiotic combination therapy in treating infections with multidrug-resistant bacteria","volume":"12,","author":"Osman","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.jgar.2025.04.005_bib0037","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1128\/AAC.01596-13","article-title":"Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections","volume":"57","author":"Henry","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.04.005_bib0038","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41429-020-0306-5","article-title":"Emergence of a multidrug-resistant ST 27 Escherichia coli co-harboring blaNDM-1, mcr-1, and fosA3 from a patient in China","volume":"73","author":"Tian","year":"2020","journal-title":"J Antibiot"},{"key":"10.1016\/j.jgar.2025.04.005_bib0039","article-title":"Development of a bacteriophage cocktail to constrain the emergence of phage-resistant Pseudomonas aeruginosa","volume":"11","author":"Yang","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2025.04.005_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/v10070351","article-title":"Resistance development to bacteriophages occurring during bacteriophage therapy","volume":"10","author":"Oechslin","year":"2018","journal-title":"Viruses"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716525000773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716525000773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T14:00:45Z","timestamp":1762610445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716525000773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":40,"alternative-id":["S2213716525000773"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2025.04.005","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of novel phages with antibiotic combinations against ESBL-producing and carbapenem-resistant Escherichia Coli","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2025.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}